Showing results (61-70 of 312) with videos related to
Sort By:
Pageof 32
Platelets|August 12, 2000
An investigation of the serotonergic effects of fenfluramine, dexfenfluramine and dexnorfenfluramine using platelets as neuronal modelsI A Jagroop, D P MikhailidisThe Journal of the Royal Society for the Promotion of Health|March 17, 1999
Cigarette smoking and erectile dysfunctionJ Y Jeremy, D P MikhailidisPlatelets|October 13, 2000
Effect of endothelin-1 on human platelet shape change: reversal of activation by naftidrofurylI A Jagroop, D P MikhailidisJournal of Human Hypertension|September 12, 2000
Angiotensin II can induce and potentiate shape change in human platelets: effect of losartanI A Jagroop, D P MikhailidisProstaglandins, Leukotrienes, and Essential Fatty Acids|October 1, 1990
Platelet-activating factor (PAF) and its relation to prostaglandins, leukotrienes and other aspects of arachidonate metabolismP V Peplow, D P MikhailidisPostgraduate Medical Journal|April 1, 1994
Unified European higher medical degreesL H Breimer, D P MikhailidisBiomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1993
Towards a doctoral thesis through published worksL H Breimer, D P MikhailidisCirculation Journal : Official Journal of the Japanese Circulation Society|July 27, 2007
Smoking and aortic diseasesA I Kakafika, D P MikhailidisJournal of Human Hypertension|April 24, 2001
Doxazosin, an alpha1-adrenoceptor antagonist, inhibits serotonin-induced shape change in human plateletsI A Jagroop, D P MikhailidisCurrent Pharmaceutical Design|February 10, 2009
Lipid-lowering drugs acting at the level of the gastrointestinal tractT D Filippatos, D P MikhailidisPageof 32